Handling of outlier (EU) [Outliers]

posted by swapnil.kuche – 2011-03-09 08:19 (4768 d 17:59 ago) – Posting: # 6730
Views: 8,646

Dear All,

Due to one outlier subject one of our pivotal study is failing. In such case can we perform redosing for approximately 20% (of original sample size) subjects to confirm the results and to support our application (MA). Nowadays this approach is used for USFDA but can you please update me regarding EU view on the same.

Thanks in advance
Swapnil

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
67 visitors (0 registered, 67 guests [including 6 identified bots]).
Forum time: 02:19 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5